Krieg, S., Fernandes, S. I., Kolliopoulos, C., Liu, M. & Fendt, S.-M. Metabolic signaling in cancer metastasis. Cancer Discov. 14, 934–952 (2024).
Google ScholarÂ
Shi, M.-Q. et al. Advances in targeting histone deacetylase for treatment of solid tumors. J. Hematol. Oncol. 17, 37 (2024).
Google ScholarÂ
Sommerhalder, D. et al. First-in-human phase 1 dose escalation study of the KAT6 inhibitor PF-07248144 in patients with advanced solid tumors. J. Clin. Oncol. 41, 1054–1054 (2023).
Google ScholarÂ
Straley, K. S. et al. Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems. Cancer Res. 84, 5795–5795 (2024).
Google ScholarÂ
McCullough, C. E. & Marmorstein, R. Molecular basis for histone acetyltransferase regulation by binding partners, associated domains, and autoacetylation. ACS Chem. Biol. 11, 632–642 (2016).
Google ScholarÂ
Bahl, S. & Seto, E. Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance. Cell. Mol. Life Sci. 78, 427–445 (2021).
Google ScholarÂ
Fukata, Y. & Fukata, M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161–175 (2010).
Google ScholarÂ
Wang, Y. et al. ZDHHC5-mediated S-palmitoylation of FAK promotes its membrane localization and epithelial-mesenchymal transition in glioma. Cell Commun. Signal. 22, 46 (2024).
Google ScholarÂ
Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).
Google ScholarÂ
Jiang, Y. et al. STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice. Sci. Signal 16, eadd2282 (2023).
Google ScholarÂ
Terry, A. R. et al. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metab. 35, 2060–2076.e2069 (2023).
Google ScholarÂ
Hao, J.-W. et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat. Commun. 11, 4765 (2020).
Google ScholarÂ
Tomić, G. et al. Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis. Cell Rep. 43, 114224 (2024).
Google ScholarÂ
Sharma, C. et al. Protein acyltransferase DHHC3 regulates breast tumor growth, oxidative stress, and senescence. Cancer Res. 77, 6880–6890 (2017).
Google ScholarÂ
Altea-Manzano, P. et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling. Nat. Cancer 4, 344–364 (2023).
Google ScholarÂ
Han, X. & Chen, J. KAT2A affects tumor metabolic reprogramming in colon cancer progression through epigenetic activation of E2F1. Hum. Cell 35, 1140–1158 (2022).
Google ScholarÂ
Lu, D. et al. KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death Dis. 12, 787 (2021).
Google ScholarÂ
Domingues, A. F. et al. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells. eLife 9, e51754 (2020).
Google ScholarÂ
Elia, I. et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature 568, 117–121 (2019).
Google ScholarÂ
Elia, I. et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat. Commun. 8, 15267 (2017).
Google ScholarÂ
Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438–2444 (2010).
Google ScholarÂ
Tolomeo, M. & Cascio, A. The multifaced role of STAT3 in cancer and its implication for anticancer therapy. Int. J. Mol. Sci. 22, 603 (2021).
Google ScholarÂ
Zhang, M. et al. A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis. Nature 586, 434–439 (2020).
Google ScholarÂ
Vandekeere, A., Fendt, S.-M., Benitah, S.-A. & Martin-Perez, M. in Methods in Cell Biology, Ch. 12 211–243 (Academic Press, 2025).
Gao, H. et al. Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 Signaling. Cell 166, 47–62 (2016).
Google ScholarÂ
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Google ScholarÂ
Geukens, T. et al. Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program. NPJ Breast Cancer 10, 31 (2024).
Google ScholarÂ
Parik, S. et al. GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide. Front. Oncol. 12, 988872 (2022).
Google ScholarÂ
Ferraro, G. B. et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat. Cancer 2, 414–428 (2021).
Google ScholarÂ
Zhang, X. H. et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67–78 (2009).
Google ScholarÂ
Garcia-Recio, S. et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat. Cancer 4, 128–147 (2023).
Google ScholarÂ
Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41–45 (2017).
Google ScholarÂ
Vandekeere, A., El Kharraz, S., Altea-Manzano, P. & Fendt, S.-M. Metabolic rewiring during metastasis: the interplay between the environment and the host. Annu. Rev. Cancer Biol. 8, 269–290 (2024).
Google ScholarÂ
Hou, S. et al. TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6. Cell Death Dis. 13, 609 (2022).
Google ScholarÂ
Gao, C., Yao, H., Liu, H., Feng, Y. & Yang, Z. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer. BMC Cancer 19, 237 (2019).
Google ScholarÂ
Chen, G. et al. Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells. Signal Transduct. Target. Ther. 7, 350 (2022).
Google ScholarÂ
Shen, Y. et al. Construction of CAR-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer. Immunol. Lett. 255, 1–9 (2023).
Google ScholarÂ
Visintin, A. et al. Novel anti-TM4SF1 antibody-drug conjugates with activity against tumor cells and tumor vasculature. Mol. Cancer Ther. 14, 1868–1876 (2015).
Google ScholarÂ
Runkle, K. B. et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol. Cell 62, 385–396 (2016).
Google ScholarÂ
Kharbanda, A., Runkle, K., Wang, W. & Witze, E. S. Induced sensitivity to EGFR inhibitors is mediated by palmitoylated cysteine 1025 of EGFR and requires oncogenic Kras. Biochem. Biophys. Res. Commun. 493, 213–219 (2017).
Google ScholarÂ
Zhang, H. et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat. Commun. 15, 4642 (2024).
Google ScholarÂ
Wingelhofer, B. et al. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer. Leukemia 32, 1713–1726 (2018).
Google ScholarÂ
Liu, Z. et al. MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma. Oncogenesis 14, 13 (2025).
Google ScholarÂ
Barré, B., Vigneron, A. & Coqueret, O. The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter. J. Biol. Chem. 280, 15673–15681 (2005).
Google ScholarÂ
Ng, I. H., Ng, D. C., Jans, D. A. & Bogoyevitch, M. A. Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes. Biochem. J. 447, 125–136 (2012).
Google ScholarÂ
Timofeeva, O. A. et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J. Biol. Chem. 287, 14192–14200 (2012).
Google ScholarÂ
Song, J., Wang, J., Tian, S. & Li, H. Discovery of STAT3 inhibitors: recent advances and future perspectives. Curr. Med. Chem. 30, 1824–1847 (2023).
Google ScholarÂ
White, J. et al. Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy. Trends Pharmacol. Sci. 45, 243–254 (2024).
Google ScholarÂ
Guo, J. et al. Perilla frutescens leaf extracts alleviate acute lung injury in mice by inhibiting KAT2A. J. Ethnopharmacol. 336, 118730 (2025).
Google ScholarÂ
Zhao, L., Pang, A. & Li, Y. Function of GCN5 in the TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer. Oncol. Lett. 16, 3955–3963 (2018).
Google ScholarÂ
von Lintig, F. C. et al. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62, 51–62 (2000).
Google ScholarÂ
Leamy, A. K. et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 55, 1478–1488 (2014).
Google ScholarÂ
Geertsma, E. R. & Dutzler, R. A versatile and efficient high-throughput cloning tool for structural biology. Biochemistry 50, 3272–3278 (2011).
Google ScholarÂ
Sun, X. et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599, 673–678 (2021).
Google ScholarÂ
Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).
Google ScholarÂ
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Google ScholarÂ
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
Google ScholarÂ
Brigidi, G. S. & Bamji, S. X. Detection of protein palmitoylation in cultured hippocampal neurons by immunoprecipitation and acyl-biotin exchange (ABE). J. Vis. Exp. 18, 50031 (2013).
Holliday, H., Khoury, A. & Swarbrick, A. Chromatin immunoprecipitation of transcription factors and histone modifications in Comma-Dβ mammary epithelial cells. STAR Protoc. 2, 100514 (2021).
Google ScholarÂ
Snyder, M., Huang, X. Y. & Zhang, J. J. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J. Biol. Chem. 286, 38886–38893 (2011).
Google ScholarÂ
